Lv1
40 积分 2025-05-20 加入
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
10个月前
已完结
Feasibility and safety of perioperative entrectinib in a patient with ROS1-positive locally advanced NSCLC: A case report
1年前
已关闭
Mutations of the EGFR, K-ras, EML4–ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma
1年前
已完结
Induction therapy with dabrafenib, trametinib, and PD-1 inhibitor and surgical conversion in unresectable stage III non-small cell lung cancers with BRAF V600E mutation: 2 cases
1年前
已完结
皖公网安备34019202002308
